BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/18/2024 9:11:52 AM | Browse: 142 | Download: 370
 |
Received |
|
2023-10-26 03:15 |
|
Peer-Review Started |
|
2023-10-26 03:15 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-11-08 06:02 |
|
Revised |
|
2023-11-21 10:27 |
|
Second Decision |
|
2024-01-02 02:50 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-01-02 07:48 |
|
Articles in Press |
|
2024-01-02 07:48 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-11 01:53 |
|
Publish the Manuscript Online |
|
2024-01-18 09:11 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Case Report |
| Article Title |
Inetetamab combined with pyrotinib and chemotherapy in the treatment of breast cancer brain metastasis: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Qing-Qing Dou, Ting-Ting Sun, Guo-Qiang Wang and Wei-Bing Tong |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wei-Bing Tong, MD, Chief Physician, Doctor, Doctor, Surgeon, Central Breast Area B, Beijing University Cancer Hospital Inner Mongolia Hospital, No. 42 Zhaowuda Road, Saihan District, Hohhot 010000, Inner Mongolia Autonomous Region, China. tongwei365@qq.com |
| Key Words |
Breast cancer brain metastasis; Resistance to trastuzumab; Macromolecule inetetamab; Small molecule tyrosine kinase inhibitor; Radiation therapy; HER2-positive; Case report |
| Core Tip |
Herein, we report the case of a patient with complex breast cancer brain metastasis. She underwent brain metastasis resection and received macromolecular mAbs, small molecule tyrosine kinase inhibitors, combination chemotherapeutic drugs, and radiation therapy. The overall condition of the patient was controlled and stabilized. We propose that combined macromolecule and small molecule chemotherapy and radiotherapy can provide a new option for the treatment of patients with breast cancer brain metastases. Magnetic resonance imaging of the brain of the patient showed that the tumor size was stable, and all the tumor indicators were within the normal range. |
| Publish Date |
2024-01-18 09:11 |
| Citation |
Dou QQ, Sun TT, Wang GQ, Tong WB. Inetetamab combined with pyrotinib and chemotherapy in the treatment of breast cancer brain metastasis: A case report. World J Clin Cases 2024; 12(3): 575-581 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i3/575.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i3.575 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
